---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-087020"
form_type: "8-K"
ticker: null
cik: "0001061027"
company_name: "Viracta Therapeutics, Inc."
filed_at: "2024-07-29T23:59:59+00:00"
generated_at: "2026-05-31T15:37:14.585953+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Viracta Therapeutics cuts ~23% of workforce; expects $0.7M severance costs

## Summary
- Reduction in force approved July 22, 2024, affecting ~23% of employees.
- Completion expected in August 2024.
- Estimated $0.7M in severance and healthcare benefits expenses.
- Company may incur additional charges not currently anticipated.

## SEC filing metadata
- accession: 0000950170-24-087020
- form_type: 8-K
- cik: 0001061027
- company_name: Viracta Therapeutics, Inc.
- filed_at: 2024-07-29T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.05
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1061027/000095017024087020/0000950170-24-087020-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1061027/000095017024087020/virx-20240722.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-087020
- JSON: https://secwatch.observer/filing/0000950170-24-087020.json
- Plain text: https://secwatch.observer/filing/0000950170-24-087020.txt

## Key facts
- Restructurings & Charges
  Viracta Therapeutics, Inc. announced a restructuring with charges of approximately $0.7 million (approximately 23% of the Company’s workforce).
  - Type: restructuring
  - Charge: approximately $0.7 million
  - Headcount: approximately 23% of the Company’s workforce
  source text: and implemented a reduction in force, to be completed in August 2024, that impacted approximately 23% of the Company’s workforce. The Company expects to recognize approximately $0.7 million in total expenses for severance and related benefits for employees laid off under the reduction in force, consisting primarily of severance payments and continued healthcare
  evidence_url: https://www.sec.gov/Archives/edgar/data/1061027/000095017024087020/0000950170-24-087020-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.